←Back to Expert Scholars
Translational Medicine / 转化医学NY-ESO-1 Vaccines, Melanoma IO
Christian Ottensmeier
MD, PhD
🏢University of Liverpool🌐UK
Professor of Immuno-Oncology
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Christian Ottensmeier has led NY-ESO-1 vaccine trials and combined cancer-testis antigen vaccination with checkpoint blockade in melanoma and other solid tumors. His translational program explores combining CT antigen vaccines with TIL therapy and checkpoint inhibitors.
Share:
🧪Research Fields 研究领域
NY-ESO-1 vaccine
peptide vaccine
melanoma immunotherapy
tumor-infiltrating lymphocytes
combination vaccine IO
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Christian Ottensmeier 的研究动态
Follow Christian Ottensmeier's research updates
留下邮箱，当我们发布与 Christian Ottensmeier（University of Liverpool）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment